• Comp Report
  • VC Report
  • Biz Report
  • About
  • Unsubscribe/Subscribe
Menu

Bullseye Consulting Group

Street Address
City, State, Zip
770-315-6331
executive compensation - venture capital - news

Your Custom Text Here

Bullseye Consulting Group

  • Comp Report
  • VC Report
  • Biz Report
  • About
  • Unsubscribe/Subscribe

Biotech, pharma investments on VC radar in 2021

December 14, 2020 Robert Harrington

The two main areas for venture capitalist (VC) investment - technology and healthcare - have grown during the COVID-19 pandemic and investors have ample dry powder to direct money at biotech and pharma firms in 2021, research firm PitchBook said on Monday. READ MORE

← How To Launch A Tech Startup And The Pitfalls To AvoidWhat investors should look for in a venture capital firm →
Summary Block
This block is invalid. Please check the block settings and try again.
Featured
Aenean eu leo Quam
Aenean eu leo Quam

Quisque iaculis facilisis lacinia. Mauris euismod pellentesque tellus sit amet mollis.

Read more →

rharrington@bullseye.consulting

       @BobJHarrington